期刊文献+

原核表达系统中HPV16L1蛋白的表达与纯化 被引量:3

Expression and Purification of Human Papillomavirus Type16 L1Protein in a Prokaryotic Expression System
下载PDF
导出
摘要 为了建立 HPV16 L1蛋白原核表达系统的纯化方法 ,纯化目的蛋白 ,我们构建了 p GEX4 T- HPV16 L1表达质粒。在大肠杆菌 BL2 1表达系统中表达 ,经过包涵体提取 ,8M尿素溶解 ,分级透析除去尿素 ,亲和层析进行提纯。结果显示 ,HPV16 L1蛋白在原核表达系统以不溶性包涵体形式存在 ,通过本方法可以获得纯化的 HPV16 L1蛋白 ,为 HPV16 This study was intended to establish a method of purification of HPV16 L1 protein expressed in a prokaryotic system and to obtain the purified protein. The prokaryotic expression vector pGEX 4T 1 HPV16 L1 was constructed and transformed into E.coli BL21 cell, and induced by 1mM IPTG to express HPV16L1 protein. The inclusion bodies were isolated and solubilized with 8M urea. After the urea was removed by gradual dialysis, the denatured L1 protein were renatured and then were purified by affinity chromatography. The results showed that HPV16L1 protein formed inclusion bodies in bacterial expression system,suggesting that this assay can be used to purify HPV16L1 protein and hence provide a basis for studying the applications of HPV16 L1 protein.
出处 《生物医学工程学杂志》 EI CAS CSCD 2002年第2期280-283,共4页 Journal of Biomedical Engineering
关键词 原核表达系统 HPV16 L1蛋白 纯化 Human papillomavirous 16 Prokaryotic expression system L1 protein Purification
  • 相关文献

参考文献2

二级参考文献5

  • 1邹承鲁.新生肽链的折叠[J].生命科学,1993,5(4):1-6. 被引量:1
  • 2Shen T,Proc Natl Acad Sci USA,1993年,90卷,8108页
  • 3Lee S C,J Biol Chem,1992年,267卷,2849页
  • 4Tsai A Y,J Biol Chem,1991年,266卷,10534页
  • 5Lin J,Proc Natl Acad Sci USA,1990年,87卷,4028页

共引文献18

同被引文献21

  • 1谷鸿喜 钟照华 等.中国妇女宫颈癌组织中HPV16L1基因的克隆与测序[J].中华微生物学和免疫学杂志,1998,18(2):95-95.
  • 2Kim SN,Jeong HS,Park SN,et al.Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae[J].J Virol Methods,2007,139(1):24-30.
  • 3Di Bonito P,Grasso F,Mochi S.et al.Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1,L2,E4,E6 and E7 proteins[J].Infect Agent Cancer,2006,1:6.
  • 4Santin AD,Bellone S,Palmieri M,et al.Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients:a phase I escalating-dose trial[J].J Virol,2008,82(4):1968-1979.
  • 5Giorgi C,Di Bonito P,Grasso F,et al.Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens[J].Infect Agent Cancer,2008,26(3):9.
  • 6Bolhassani A,Zahedifard F,Taslimi Y,et al.Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients[J].Indian J Med Res,2009,130(5):533-541.
  • 7Laukkanen P,Lr E,Koskela P,et al.Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses[J].Future Oncol,2010,6(5):709-716.
  • 8Hein K,Christense ND, Hoepft R,et al. Serum IgG IgM and IgA reactivity to human papil/omavirus types 11 and 6 virus-like-particles in different gynecologic patient groups [J]. J lnfect Dis, 1995, 172: 392-402.
  • 9Catter JJ ,Wipf GC, Hagensee ME,et al. Use of papillomavirus type 6 capsids to detect antibodies in people with genital warts[J]. J Infect Dis,1995,172:11-18.
  • 10胥俊峰,单建华,赵宁伟,殷志敏.大肠杆菌γ-ggt原核表达载体pGEX-4T-1/γ-ggt的构建及其蛋白表达[J].安徽农业科学,2007,35(30):9467-9469. 被引量:3

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部